Speakers

Adrian was appointed as Managing Director of Imperial College Health Partners in April 2013.

Dr Bull began his medical career by serving for six years in clinical practice in the Royal Navy, qualifying MRCGP, before continuing as an epidemiologist and Public Health consultant in the NHS. He has been the Medical Director of an NHS trust and held senior executive positions at PPP Healthcare, Carillion and Humana. From 2008 to 2013 he was Chief Executive of Queen Victoria Hospital NHS Foundation Trust.

Adrienne Boissy, MD, MA, is the Chief Experience Officer (CXO) of Cleveland Clinic.  She is a staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis and has a secondary appointment in Bioethics. Before becoming part of the executive team, she served as the Medical Director of the Center of Excellence in Healthcare Communication (CEHC). Her team created a comprehensive program to strengthen physician and provider communication skills throughout and has trained more than 5,000 clinicians to date. That experience was worth writing about and a book is in the works!

 
She currently serves as Editor in Chief of the Journal of Patient Experience. She was awarded the humanism in medicine grant from the Arnold P. Gold Foundation and is a Harvard Macy Scholar. She has an unbridled passion for relentlessly driving improvements in patient and caregiver experience in creative, inspiring ways, while also recognizing the need for thoughtful, rigorous approaches.

Elizabeth Teisberg is a Professor at Dartmouth’s Medical School and a Senior Institute Associate at Harvard's Institute for Strategy and Competitiveness. 

Her expertise is in Strategy and Innovation, particularly in health care delivery. Prof. Teisberg wrote Redefining Health Care: Creating Value-Based Competition on Results with Professor Michael E. Porter. Since its publication, she has worked internationally to inspire and implement innovation for dramatic improvement in health care value.  Her recent publications include “Value for Patients,” “The Experience Group Handbook,” “Measuring What Matters:  Connecting Excellence, Professionalism and Empathy,” “The Quality Tower of Babel,” “The Imperative and Opportunity of Chronic Disease” and “Four Ways to Reinvent Service Delivery.” She is currently working on a book on the implementation of value-based health care delivery.

Prof. Teisberg earned a Ph.D in engineering from Stanford University and graduated summa cum laude from Washington University in St. Louis.

Jonathan is Medical Director Medicine Board at University College London Hospitals. He is one of 4 medical directors at the trust; known for its strong clinical leadership model, excellent outcomes for patients and strong research. He continues his work as an Intensive Care physician at the ICU based in the main hospital; is a governing body member for Aylesbury CCG, a Board member for HealthServices Laboratories (UCLH-RFL-TDL Pathology Joint Venture) and Board Trustee at The Nuffield Trust.
 
Prior to UCLH he was Chief Medical Officer at the Royal Berkshire NHS Foundation Trust in Reading; appointed in 1998 as a consultant in anaesthesia and intensive care medicine and previous posts as Clinical Director Emergency Care, Emergency Care Lead and Director of Medical Education and Development.

In addition to his clinical roles Jonathan held the post of Deputy, then Chairman of the Central Consultants and Specialists Committee (CCSC) BMA and has worked on numerous national bodies on behalf of the Department of Health and advisory bodies to ministers and the Secretary of State for Health. Currently he is one of 2 employer members of the national Advisory Committee on Clinical Excellence and since 2014 he acts as a Chair for CQC inspections.

Kamalini Ramdas is Professor of Management Science and Operations at London Business School and Deloitte Chair of Innovation and Entrepreneurship. She is currently an Associate Editor at Management Science and has served as a past Departmental Editor of the Entrepreneurship and Innovation Department of Management Science. Kamalini is an expert in the area of innovation. Her recent work examines new ways to create value through innovation, including service innovation and operational innovation. She presents some of this work in her recent TEDx talk. Kamalini is co-principal investigator on a $1.2 million grant to model and implement profitable cardiac preventive care via delivery innovation. She is also examining operational innovation in an array of service industries supported by a £50,000 grant from the UK Economic and Social Research Council.

Kamalini’s past research has examined questions surrounding the issue of how much product variety and component-level variety firms should offer and how variety can be managed effectively through design. This work involved examining the cost, quality and revenue impact of a firm’s product design decisions. 

Kamalini has taught at the University of Virginia, University of Texas at Austin, The Wharton School, and the Indian School of Business, Hyderabad. She is regularly invited to speak on innovation, service design and delivery. Recent talks include Harvard, Wharton, Columbia, Stanford and the World Economic Forum Davos 2011.

Sir Malcolm is former President and Provost of UCL (2003-2013) and a former Governor of London Business School. Since 2011 he has been chairman of NHS England, the independent body set up by Parliament with responsibility for investing the annual budget of over £100 bn in securing the highest quality of healthcare for the population of England. He is Chancellor of the University of York, and also a director of Genomics England Ltd, an adviser on higher education to the governments of Hong Kong and Russia, presidential adviser at Arizona State University, president of the Council for At-Risk Academics (CARA), and a UK Business Ambassador.

The increasing complexity and costs of medical care are challenging healthcare organizations to develop efficient and high quality care models.  Cleveland Clinic has found that Shared Medical Appointments (SMA’s) provide one innovative solution.    

As a practicing Internal medicine/paediatric physician, Marianne has introduced Shared Medical Appointments (SMA)  at the practice since 1999 for women’s wellness and asthma care. As medical director of Cleveland Clinic’s SMA program, Marianne oversees the implementation and execution of over 75 SMA’s. Their program expands over multiple outpatient and inpatient settings providing a rich experience of over 20,000 SMA visits having been conducted.   

Marianne has presented internationally at the Australian & New Zealand Obesity Society and the Australian Lifestyle Medicine Association‘s Annual Scientific Meeting, sharing best practice models.  Most recently she presented the experience at the Institute for Healthcare Improvement’s Annual International summit and directed a workshop for SMA implementation providing insight and tips on implementation.  Marianne’s experience with SMAs supports a positive impact on disease management, access to care, quality of care and enhanced patient and provider experience.  Given the future direction and needs of healthcare, SMA’s can transform the way we deliver care in a complex and fast-changing environment.

Mike is a senior partner in Deloitte's global Lifescience and Healthcare practice. He acts as a strategic advisor and leads transformational programmes for major pharmaceutical companies, healthcare systems, medical charities and governments. His clients include Amgen, BMS, Roche, Sanofi, NHS England, Macmillan Cancer Support, Wellcome Trust and the UK Government. His areas of expertise include:

Leading corporate strategy programmes for leading pharma and medical device companies focusing on portfolio restructuring, business growth, turnarounds and organisational redesign.

Launched globally, next generation drugs and medical devices to treat cancer, heart disease, diabetics and hepatitis. He has developed new approaches to pricing, market access and market activation. He developed the UK government's programme to accelerate the development and adoption of medical innovations.

Developed new models of care for cancer and diabetics, integrating drugs, protocols and devices. Redesigned national cardiovascular comorbidity treatment programmes and clinical pathways for the major cancers (breast, brain and CRC). 

Designed 'cluster strategies' for national governments and regional health economies. He advises on national digital healthcare and genomics programmes.

Mike is a founder member of GMEC, Europe's largest medical cluster, which links Oxford and Cambridge Universities with UCL, Imperial and Kings College. He is also an Advisory Board member of the Wellcome Trust Centre of Human Genetics.

Prior to joining Deloitte, he led Monitor Group's European Lifescience practice and built Gemini / Cap Gemini's global Lifescience business unit.

Nicos Savva is an Associate Professor of Management Science and Operations at the London Business School, where he teaches courses on modelling and healthcare management. Nicos’ research examines hospital operations and innovation and has appeared in leading journals such as Management Science and Nature Biotechnology. Nicos holds a PhD in Management Science, an MPhil in Finance and a BA in Physics, all from the University of Cambridge.

Rengaraj Venkatesh is the Chief Medical Officer at the Aravind Eye Hospital, Pondicherry. He completed his ophthalmic residency in Aravind Eye Hospital, Madurai and joined as consultant in the same hospital. Since then he is actively involved in clinical activities, teaching, and research work and also plays an active role in consultancy and capacity building of eye hospitals in the developing world through the consulting division of Aravind Eye Care System – LAICO. 

Dr. Venkatesh is actively involved in incremental innovations to already practiced health care delivery model of Aravind. He has played a vital role in new school screening model by training all class teachers of schools, which challenges the historical volunteer teacher-training model. He is at present working on an innovative and novel outreach model to detect vision threatening eye problems at an early stage using low cost technology, which is found to be more productive than the existing outreach model. He is also working on many new projects to promote awareness about eye diseases, to encourage follow-up of chronic conditions that include the piloting of shared medical appointments.

Saul joined Index in 2007, and was a partner until May 2015. A serial entrepreneur with two decades of experience building and exiting companies in both the US, Israel and Europe, Saul has a passion for working with seed and early stage businesses. Most recently he co-founded Kano and Seedcamp, as well as co-founder and original CEO of Lovefilm International (acquired by Amazon). He was also part of the original executive team at Skype (acquired by eBay). Saul believes tech is still only just starting to make a dent on the economy and society and that it has the potential to create hundreds of thousands of jobs.

Steven Kaufman MD, Deputy Medical Director of Cooper Health System’s Urban Health Institute and Assistant Professor of Medicine at the Cooper Medical School at Rowan University (CMSRU). He is a board certified endocrinologist whose urban health efforts are focused on the decreasing disparities in the management of chronic illness.   

His early work in urban health with the Camden Coalition of Healthcare Providers focused on practice level innovations in diabetes care within primary care offices in the resource poor community of Camden, NJ. 

In 2013 he transitioned to the Deputy Medical Director of Cooper University Hospital’s Urban Health Institute. He heads an interdisciplinary team implementing innovative health care delivery through open access scheduling, shared medical visits and improved clinical efficiency across twenty-three medical and surgical specialties. 

Dr. Kaufman’s additional roles include Interim Division Head for Endocrinology, Medical Director of the Cooper Diabetes Center, Medical Director of the hospital’s Inpatient Glycemic Control Task Force and Course Director for the CMSRU Interdisciplinary Chronic Care Clerkship. 

Dr. Kaufman graduated with honors from Rutgers University with his Bachelor of Arts. He received his medical degree from Temple University for before completing his residency in Internal Medicine at Case Western Reserve University and, fellowship in Endocrinology and Metabolism at the University of Pittsburgh.

Stuart Fletcher is Chief Executive Officer of Bupa, the global health and care company, a role he has held since March 2012. 

Bupa is a leading global health and care group providing health insurance, medical subscriptions services, care homes, hospitals, clinics, dentistry and a range of other health and care services.  With almost 80,000 people in operations around the world dedicated to having people live longer, healthier, happier lives, the company’s no-shareholder status allows it to reinvest its surplus to provide more and better healthcare.

Bupa achieved revenues of £9.8 billion and profits of £637.8 million in 2014, has 29 million customers in over 190 countries and almost 80,000 employees.

Stuart was previously President, Diageo International between 2004-2011, having been President, Key Markets 2000-2004.  Stuart held a number of other senior management positions at Diageo, joining the company in 1986, including as Global Finance Director, Guinness.  Previously Stuart held various financial roles with Procter & Gamble.

Thulasiraj is part of the senior leadership team of Aravind since 1981. Aravind Eye Hospital is a large provider of eye care, known for its sustainable, scalable and replicable model of service delivery.  Thulsi was instrumental in establishing Aravind’s systems and processes that are being replicated by hospitals across the developing world. 

In line with organization’s mission to eliminate needless blindness, Thulasiraj along with his team have mentored over 300 eye hospitals across the globe, often resulting in doubling of their output in the year following the engagement.  As head of Aravind’s technology department, he helped Aravind become one of the pioneer hospital in the country to adopt the Information Technology. This and other initiatives led Aravind to appear in Fast Co.’s list of the 50 most innovative companies in the world. Aravind Eye Care System was awarded the Gates Award for Global Health, the Champalimaud Award, and more recently the Conrad Hilton Humanitarian award. 
 
Thulasiraj has been an Advisor to India’s National Programme for the Control of Blindness (NPCB) and WHO. He was the Regional Chair of the International Agency for the Prevention of Blindness and was the founder President of Vision 2020 India. 

Thulasiraj was named as a Social Entrepreneur in 2005 by the Schwab Foundation (World Economic Forum); adjudged the “Hospital Administrator of the Year in 2008” in India by Modern Medicare and GE Health; speaker at the TED Conference, India in 2009; listed among the 30 Most Influential People in Public Health globally by a portal on Masters in Public Health Management; in 2014, honoured as the “Most inspiring Healthcare Leader of the year” by Times of India Group.

Delos M. Cosgrove MD, is President and CEO of Cleveland Clinic. He heads a $6 billion healthcare system comprised of Cleveland Clinic, 8 community hospitals, 16 family health and surgery centers, Cleveland Clinic Florida, Lou Ruvo Center for Brain Health, Las Vegas, Cleveland Clinic Toronto, and Cleveland Clinic Abu Dhabi. 

Dr. Cosgrove received his medical degree from University of Virginia School of Medicine, completed clinical training at Massachusetts General Hospital, and Brook General Hospital in London. He earned an undergraduate degree from Williams College, Williamstown, Massachusetts. In 1967, he was a surgeon in the U.S. Air Force, serving in Da Nang, Vietnam.  He was awarded the Bronze Star and Republic of Vietnam Commendation Medal. 

Dr. Cosgrove joined the Cleveland Clinic in 1975, and was named chairman of the Department of Thoracic and Cardiovascular surgery in 1989. He performed over 22,000 operations and earned an international reputation in cardiac surgery valve repair before his retirement in 2006. He holds 30 patents for medical innovations.

He has received numerous awards and is ranked among Modern Healthcare’s “100 most powerful people in healthcare” and “most powerful physician executives.” His book, “The Cleveland Clinic Way” was published by McGraw-Hill Education in 2014.